Wednesday, October 21, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 16.6
NASDAQ 100 earnings season is producing sharp divergence: a broad cohort of consumer, industrial, healthcare and software names beat estimates and jumped to or near 52-week highs, while AI/semiconductor and datacenter-infrastructure names (NVDA, AMD, MU, AMAT, KLAC, ARM, CRWV, NBIS, RKLB) sold off double digits on the same day. Breadth of earnings beats is encouraging, but mega-cap tech (GOOGL, META, NFLX) and chip supply-chain names remain under pressure, keeping the overall tape mixed rather than broadly risk-on.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | ISRG | SKIP | — | $429.73 → $451.38 stop $390.19 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | FAST | SKIP | — | $52.80 → $55.44 stop $49.16 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #3 | CTAS | SKIP | — | $220.00 → $231.00 stop $206.14 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #4 | ROP | SKIP | — | $396.36 → $416.17 stop $372.18 |
Position cap reached — 85 of 20 slots in use. |
Already open: LGEN.L (to Oct 21), SSE.L (to Oct 21), AAPL (to Oct 22), KGF.L (to Oct 23), DCC.L (to Oct 25), DPLM.L (to Oct 28), EMR (to Nov 1), ALW.L (to Nov 1), PSN.L (to Nov 1), MSFT (to Nov 4), ADI (to Nov 4), SVT.L (to Nov 5) … and 73 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Intuitive Surgical makes the da Vinci robotic surgery systems used in hospitals worldwide. The company just reported quarterly results (released yesterday) that beat Wall Street's expectations by a wide margin, with revenue up 22% and more hospitals buying and using its systems than ever before, and the stock still trades well below its 52-week high. The main risks are a recently disclosed $450 million legal settlement charge and some insiders selling shares.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Fastenal sells nuts, bolts, and other industrial supplies to factories and construction sites. Its shares are sitting near 52-week highs, climbing steadily with healthy supporting volume, and are beating the overall market by a wide margin over the past month. The main risks are some recent insider selling and the chance that this already-strong run simply cools off.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Cintas supplies uniforms, cleaning supplies and safety gear to businesses across the country on a subscription-like basis. The company just reported record revenue and profit margins and raised its full-year sales and earnings forecast, and management sounded genuinely upbeat rather than hedging. The main risk is that the stock has already climbed steeply and sits right at its 52-week high, so some of this good news may already be reflected in the price.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Roper Technologies is a diversified owner of specialized software and technology businesses. Shares have climbed steadily, are beating the broader market, and sit above both their short- and long-term trend lines. The biggest risk right now is that the company reports earnings tomorrow, which could send the stock sharply higher or lower depending on the results.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 20, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 101 NASDAQ 100 constituents and short-listed 27 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.